A phase II study of the combination of liposomal doxorubicin (LD) and gemcitabine (G) in patients with relapsed ovarian cancer after chemotherapy containing platinum compounds.

被引：0
|
作者：
Gambino, A [1 ]
Tognon, G [1 ]
Galleri, G [1 ]
Agoni, L [1 ]
Pecorelli, S [1 ]
机构：
[1] Univ Studi, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492S / 492S
页数：1
相关论文
共 50 条
  • [1] Gemcitabine (G) and liposomal doxorubicin (D) in patients with recurrence of ovarian cancer after chemotherapy containing platinum compounds: a phase II study
    Gambino, Angela
    Tognon, Germana
    Galleri, Guido
    Agoni, Lorenzo
    Pecorelli, Sergio
    ANNALS OF ONCOLOGY, 2004, 15 : 129 - 129
  • [2] A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
    Mirza, Mansoor Raza
    Lund, Bente
    Lindegaard, Jacob Christian
    Keldsen, Nina
    Mellemgaard, Anders
    Christensen, Rene dePont
    Bertelsen, Kamma
    GYNECOLOGIC ONCOLOGY, 2010, 119 (01) : 26 - 31
  • [3] Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer
    D'Agostino, G
    Ferrandina, G
    Garganese, G
    Salerno, MG
    Lorusso, D
    Farnetano, MG
    Mancuso, S
    Scambia, G
    ONCOLOGY, 2002, 62 (02) : 110 - 114
  • [4] A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens
    Scambia, G.
    Parma, G.
    Del Conte, G.
    Hess, D.
    Gadducci, A.
    Katsaros, D.
    Sessa, C.
    Trudel, G. C.
    Coceani, N.
    Colombo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] CARBOPLATIN (CBDCA) PLUS LIPOSOMAL DOXORUBICIN (LD) IN PLATINUM SENSITIVE OVARIAN CANCER: A PHASE II STUDY
    Cianci, Claudia
    Di Donato, Samantha
    Gadducci, Angiolo
    Cosio, Stefania
    Pastina, Ilaria
    Fanucchi, Antonio
    Orlandini, Cinzia
    Ricci, Sergio
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [6] Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer.
    Vorobiof, DA
    Rapoport, B
    Slabber, C
    Eek, R
    Cohen, G
    Alberts, AS
    McMichael, GB
    Raats, J
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 471S - 471S
  • [7] Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer
    G D'Agostino
    G Ferrandina
    M Ludovisi
    A Testa
    D Lorusso
    N Gbaguidi
    E Breda
    S Mancuso
    G Scambia
    British Journal of Cancer, 2003, 89 : 1180 - 1184
  • [8] PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER
    Ferrandina, G.
    Paris, I.
    D'Agostino, G.
    Ludovisi, M.
    Zanghi, M.
    Lorusso, D.
    Testa, A. C.
    Scandurra, G.
    Pisconti, S.
    Pezzella, G.
    Adamo, V.
    Scambia, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 98 - 98
  • [9] Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer
    D'Agostino, G
    Ferrandina, G
    Ludovisi, M
    Testa, A
    Lorusso, D
    Gbaguidi, N
    Breda, E
    Mancuso, S
    Scambia, G
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1180 - 1184
  • [10] Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Arun, B
    Royce, M
    Adinin, R
    Hoelzer, K
    Walters, R
    Wade, JL
    Pusztai, L
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3249 - 3254
12345